Cargando…

Identification of In Vitro Metabolites of Amoxicillin in Human Liver Microsomes by LC–ESI/MS

Amoxicillin (AMOX) metabolism in human liver microsomes was studied in vitro using liquid chromatography–mass spectrometry (LC/MS). Amoxicillin was incubated with human liver microsomes along with NADPH, and the reaction mixture was analyzed by LC/MS to obtain the specific metabolic profile of the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Szultka, Malgorzata, Krzeminski, Rafal, Jackowski, Marek, Buszewski, Boguslaw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111861/
https://www.ncbi.nlm.nih.gov/pubmed/25089048
http://dx.doi.org/10.1007/s10337-014-2648-2
_version_ 1782328132042227712
author Szultka, Malgorzata
Krzeminski, Rafal
Jackowski, Marek
Buszewski, Boguslaw
author_facet Szultka, Malgorzata
Krzeminski, Rafal
Jackowski, Marek
Buszewski, Boguslaw
author_sort Szultka, Malgorzata
collection PubMed
description Amoxicillin (AMOX) metabolism in human liver microsomes was studied in vitro using liquid chromatography–mass spectrometry (LC/MS). Amoxicillin was incubated with human liver microsomes along with NADPH, and the reaction mixture was analyzed by LC/MS to obtain the specific metabolic profile of the studied antibiotic drug. Positive electrospray ionization was employed as the ionization source. An ACE C18-column (4.6 mm × 150 mm, 3 μm) was implemented with acetonitrile and water (+0.1 % formic acid) in isocratic mode as the mobile phase at the flow 0.4 mL min(−1). The chemical structures of metabolites were proposed on the basis of the accurate mass measurement of the protonated molecule as well as their main product. Six phase I and one phase II metabolites were detected and structurally described. The metabolism of AMOX occurred via oxidation, hydroxylation and oxidative deamination, as well as through combination of these reactions. Compound M7, with glucuronic acid was also observed as phase II metabolite. Neither sulfate nor glutathione conjugates were detected. This study presents novel information about the chemical structure of the potential AMOX metabolites and provides vital data for further pharmacokinetic and in vivo metabolism studies.
format Online
Article
Text
id pubmed-4111861
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-41118612014-07-30 Identification of In Vitro Metabolites of Amoxicillin in Human Liver Microsomes by LC–ESI/MS Szultka, Malgorzata Krzeminski, Rafal Jackowski, Marek Buszewski, Boguslaw Chromatographia Original Amoxicillin (AMOX) metabolism in human liver microsomes was studied in vitro using liquid chromatography–mass spectrometry (LC/MS). Amoxicillin was incubated with human liver microsomes along with NADPH, and the reaction mixture was analyzed by LC/MS to obtain the specific metabolic profile of the studied antibiotic drug. Positive electrospray ionization was employed as the ionization source. An ACE C18-column (4.6 mm × 150 mm, 3 μm) was implemented with acetonitrile and water (+0.1 % formic acid) in isocratic mode as the mobile phase at the flow 0.4 mL min(−1). The chemical structures of metabolites were proposed on the basis of the accurate mass measurement of the protonated molecule as well as their main product. Six phase I and one phase II metabolites were detected and structurally described. The metabolism of AMOX occurred via oxidation, hydroxylation and oxidative deamination, as well as through combination of these reactions. Compound M7, with glucuronic acid was also observed as phase II metabolite. Neither sulfate nor glutathione conjugates were detected. This study presents novel information about the chemical structure of the potential AMOX metabolites and provides vital data for further pharmacokinetic and in vivo metabolism studies. Springer Berlin Heidelberg 2014-03-22 2014 /pmc/articles/PMC4111861/ /pubmed/25089048 http://dx.doi.org/10.1007/s10337-014-2648-2 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original
Szultka, Malgorzata
Krzeminski, Rafal
Jackowski, Marek
Buszewski, Boguslaw
Identification of In Vitro Metabolites of Amoxicillin in Human Liver Microsomes by LC–ESI/MS
title Identification of In Vitro Metabolites of Amoxicillin in Human Liver Microsomes by LC–ESI/MS
title_full Identification of In Vitro Metabolites of Amoxicillin in Human Liver Microsomes by LC–ESI/MS
title_fullStr Identification of In Vitro Metabolites of Amoxicillin in Human Liver Microsomes by LC–ESI/MS
title_full_unstemmed Identification of In Vitro Metabolites of Amoxicillin in Human Liver Microsomes by LC–ESI/MS
title_short Identification of In Vitro Metabolites of Amoxicillin in Human Liver Microsomes by LC–ESI/MS
title_sort identification of in vitro metabolites of amoxicillin in human liver microsomes by lc–esi/ms
topic Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111861/
https://www.ncbi.nlm.nih.gov/pubmed/25089048
http://dx.doi.org/10.1007/s10337-014-2648-2
work_keys_str_mv AT szultkamalgorzata identificationofinvitrometabolitesofamoxicillininhumanlivermicrosomesbylcesims
AT krzeminskirafal identificationofinvitrometabolitesofamoxicillininhumanlivermicrosomesbylcesims
AT jackowskimarek identificationofinvitrometabolitesofamoxicillininhumanlivermicrosomesbylcesims
AT buszewskiboguslaw identificationofinvitrometabolitesofamoxicillininhumanlivermicrosomesbylcesims